References
- Gummin DD, Mowry JB, Spyker DA, et al. 2018 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th annual report. Clin Toxicol (Phila)). 2019;57(12):1220–1413.
- Wellbutrin [package insert]. Bridgewater, NJ: Bausch Health US, 2019.
- Heise CW, Skolnik AB, Raschke RA, et al. Two cases of refractory cardiogenic shock secondary to bupropion successfully treated with veno-arterial extracorporeal membrane oxygenation. J Med Toxicol. 2016;12(3):301–304.
- Chhabra N, Deslauriers C, Wahl M, et al. Management of severe bupropion poisoning with intravenous lipid emulsion. Clin Toxicol (Phila)). 2018;56(1):51–54.
- Sirianni AJ, Osterhoudt KC, Calello DP, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008;51(4):412–415.e1.
- Lee HM, Archer JR, Dargan PI, et al. What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient? Clin Toxicol (Phila)). 2015;53(3):145–150.
- Wu P, Juurlink D. 2016. Bupropion. In: Brent J, Burkhart K, Dargan P, Hatten B, Megarbane B, Palmer R., editors. Critical care toxicology. Cham (Switzerland): Springer.
- Al-Abri SA, Orengo JP, Hayashi S, et al. Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion. Clin Toxicol (Phila)). 2013;51(10):1230–1234.